GSK248233A
GSK248233A is a dual inhibitor of Fluc and VEGFR2 with IC50 of 1.03 μM and 2 nM, respectively. GSK248233A also shows activity against the AGC family. GSK248233A acts as a protein kinase inhibitor across ATP-dependent and -independent luciferases with potential implications for Fluc reporter assays.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 850665-21-3
- Formel: C25H24N8O3
- Molecular Weight:484.51
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle VEGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Sf9 | IC50 |
2 nM
Compound: 6h
|
Inhibition of human ROCK1 in Sf9 cells
Inhibition of human ROCK1 in Sf9 cells
|
[PMID: 17201404] |
Chemical Information
-
CAS. Nr. 850665-21-3
-
Molecular Weight 484.51
-
Formel C25H24N8O3
-
SMILES
O=C(C1=CC=C(N(C)C)C=C1)NC2=CC(OC3=CC(N(CC)C(C4=NON=C4N)=N5)=C5C=N3)=CC=C2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)